Sanofi and Translate Bio to develop mRNA vaccine

27 March 2020 (Last Updated March 27th, 2020 11:40)

Sanofi vaccines division Sanofi Pasteur has partnered with Translate Bio for the development of a messenger RNA (mRNA) vaccine against Covid-19.

Translate Bio has already started the production of several mRNA constructs. The company will leverage its mRNA platform for the discovery, design and manufacture of SARS-CoV-2 vaccine candidates.

Sanofi will contribute via its vaccine expertise and external research networks support. The aim is to progress vaccine candidates for further development.

Read the full article here